BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 7860576)

  • 21. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of patients for chronic pulmonary tuberculosis with expectoration--selection and tolerance to drugs].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):172-80. PubMed ID: 9489412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of multidrug-resistant Mycobacterium tuberculosis isolates in Georgetown, Guyana.
    Menner N; Günther I; Orawa H; Roth A; Rambajan I; Wagner J; Hahn H; Persaud S; Ignatius R
    Trop Med Int Health; 2005 Dec; 10(12):1215-8. PubMed ID: 16359400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summaries for patients. Treatment outcomes for patients with multidrug-resistant tuberculosis.
    Ann Intern Med; 2006 May; 144(9):I18. PubMed ID: 16670128
    [No Abstract]   [Full Text] [Related]  

  • 25. Periodic or routine susceptibility testing in tuberculosis control.
    Kalk A
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):176-7; author reply 177-9. PubMed ID: 11931421
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
    Zhukova MP
    Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Chen QL; Chen L; Yin JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multidrug-resistant tuberculosis in Romania].
    Stoicescu IP; Didilescu C; Bercea O
    Pneumoftiziologia; 1997; 46(3):161-78. PubMed ID: 9654954
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term results of treatment of drug-resistant pulmonary tuberculosis in adolescents].
    Firsova VA; Poluĕktova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2005; (7):25-8. PubMed ID: 16130423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug susceptibility of tuberculosis isolates in Kansas, 1992-1993.
    Kans Med; 1994 Jun; 95(6):147-8. PubMed ID: 7933767
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.
    Aparna SB; Reddy VC; Gokhale S; Moorthy KV
    Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):564-70. PubMed ID: 19243801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Guidelines for chemotherapy of tuberculosis. German Central Committee for the Control of Tuberculosis].
    Ferlinz R
    Pneumologie; 1995 Mar; 49(3):217-25. PubMed ID: 7753768
    [No Abstract]   [Full Text] [Related]  

  • 36. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-resistant tuberculosis: response to treatment.
    Saenghirunvattana S; Charoenpan P; Vathesatogkit P; Kiatboonsri S; Aeursudkij B
    J Med Assoc Thai; 1996 Sep; 79(9):601-3. PubMed ID: 8996991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis: treating multi-drug resistance.
    Nurs Stand; 1998 Apr 1-7; 12(28):32. PubMed ID: 9616622
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sparfloxacin in combined therapy for pulmonary tuberculosis].
    Sokolova GB; Khaĭmenova TIu; Lazareva IaV; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):21-7. PubMed ID: 19069178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Spread of drug-resistant strains of mycobacterium tuberculosis among patients with isolated bacteria].
    Zhukova MP
    Probl Tuberk; 1998; (1):14-6. PubMed ID: 9553424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.